|
|
|
|
|
|
|
|
|
|
|
Cancer care in the time of COVID-19 and after
|
| From our sister publication, Managed Healthcare Executive®: Patients and their
oncologists are weighing the pros and cons of delaying treatment. Once the outbreak
subsides, how might the practice of oncology change?
|
|
Read more
|
|
|
|
|
ADVERTISEMENT
|
|
|
|
|
